Chester Medical Solutions to invest £500,000 in carton plant

Published: 10-Jun-2010
Packaging Finance

Pharmaceutical contract packer extends North Wales facility to meet growth

Chester Medical Solutions has invested around £500,000 in new printing equipment and on extending its printing operation in Deeside, North Wales, by 10,000ft2, taking the total area to 30,000ft2.

The company plans to install new pre-press and finishing equipment, which will enable it to upgrade the site to obtain PS9000 accreditation for pharmaceutical packaging.

‘This is a significant step forward for Chester Medical, both in terms of additional capacity to meet market demand and our ability to go forward to obtain PS9000 accreditation,’ said managing director David Patterson.

‘In particular, it demonstrates yet again our commitment to meeting the continually changing and developing needs of the marketplace.’

The firm is already accredited by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for a variety of packaging requirements and holds the MHRA’s MIA (IMP) Licence for Investigational Medicinal Products.

The company also holds Controlled Drug and Veterinary licences and has achieved ISO 13485 certification for the packaging of medical devices.

Chester Medical’s products and services include blister packs, pot and bottle filling and peel pouch packing and assembly.

  • Companies:
  • Chester Medical Solutions
See more

You may also like

Manufacturing

Knowledge and adaptability drive successful pharmaceutical outsourcing partnerships

Read more
Third-party contract manufacturers and packers play an increasingly prominent role in the pharmaceutical sector, helping companies to both navigate the complexities of the market and capitalise on new opportunities

Trending Articles

  1. Vetter strengthens senior management team for growth Three new managing directors to support global sustainable development
  2. Dual-chamber packaging systems as a simplification factor in the supply chain Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma
  3. AstraZeneca to stop production of Pulmicort pMDI Agreements with SkyePharma expected to be terminated
  4. Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Manufacturing

Knowledge and adaptability drive successful pharmaceutical outsourcing partnerships

Third-party contract manufacturers and packers play an increasingly prominent role in the pharmaceutical sector, helping companies to both navigate the complexities of the market and capitalise on new opportunities
Manufacturing

Despite unprecedented supply chain pressures, BCMPA members continue to deliver

Emma Verkaik, Membership and Marketing Director at the BCMPA — the Association for Contract Manufacturing, Packing, Fulfilment & Logistics — learns how members in the pharmaceutical sector are overcoming significant supply chain delays and providing ever more agile and responsive alternative solutions for clients
Packaging

Chester Medical invests in Bobst glue line

At its carton and leaflet manufacturing plant in Deeside, Flintshire, UK
Packaging

Chester Medical installs digital carton printer for Braille

Suitable for short print runs and digitally printed cartons
Packaging

Chester Medical unveils expansion plans

Will move into new Deeside building that is double the size of existing premises
Manufacturing

Leybold launches Duradry vacuum pump for harsh processes

Advanced technology designed for reliability and efficiency
Packaging

How pharma packaging manufacturers role is evolving: the case of extractables testing

As the pharmaceutical industry continues to grow and evolve, extractables testing is a critical component of the pharmaceutical industry's efforts to prioritise quality and safety, ensuring one of the key functions pharma containers are designed for, says Anna Malori, Head of Product Management at Bormioli Pharma
Subscribe now